McKnight's March 14, 2023
Alicia Lasek

The Food and Drug Administration has issued a notice detailing the COVID-19-related guidances that will expire when the public health emergency (PHE) ends as scheduled on May 11, and which guidances will remain in effect.

The Department of Health and Human Services announced the PHE’s end date in January, and the notice is intended to clarify which guidance documents are tied to the duration of the PHE declaration and those that are being revised to remain in effect, the FDA explained.

In addition, some of the PHE guidances and policies will merit an additional 180-day “wind-down period” in order to ensure an orderly transition, the FDA stated. These will expire by Nov. 7.

The Centers for Medicare & Medicaid...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: CMS, FDA, Govt Agencies, Healthcare System, Post-Acute Care, Provider, Public Health / COVID
Use AI to regulate AI, Google executive says
The Current State Of 521 FDA-Approved, AI-Based Medical Devices
Elon Musk’s Neuralink Wants To Put Chips In Our Brains — How It Works And Who Else Is Doing It
Over-the-Counter Hearing Aids — Using Regulatory Policy to Improve Public Health
FDA Updates Cybersecurity Guidance

Share This Article